Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents

Haploidentical Hematopoietic Stem Cell Transplantation Clinical Trial

Official title:
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents

Status Recruiting

Clinical Trial Summary

Purpose of study: This phase I/II trial is to evaluate the safety and feasibility of TCRαβ-depleted graft from haploidentical family donors in treating children and adolescents with malignant or non-malignant diseases.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Haploidentical Hematopoietic Stem Cell Transplantation
Malignant Disease
Non-malignant Disease

Clinical Trial Details

NCT number	NCT02014506
Study type	Interventional
Source	Asan Medical Center
Contact	Ho Joon Im, MD, PhD
Phone	82-2-3010-3371
Email	hojim@amc.seoul.kr
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	January 2017
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05622032` - Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study
Recruiting	`NCT06041893` - Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide
Recruiting	`NCT06423131` - Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT	N/A
Recruiting	`NCT05166967` - Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation	Phase 4
Active, not recruiting	`NCT04778618` - Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation	Phase 2
Completed	`NCT03236220` - Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation	Phase 2
Recruiting	`NCT06381817` - Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients	Phase 3